INCR.US
INCR.US
Last Day
Drug Manufacturers – Specialty & Generic
Latest Valuation
- Trailing PE:
- Forward PE:
- Price Sales TTM:
- Price Book MRQ:
- Enterprise Value:
- Enterprise Value Revenue:
- Enterprise Value Ebitda:
- Beta:
Key Highlights
- Shares Outstanding:
- Market Capitalization:
- Market Capitalization Mln:
- EBITDA:
- PE Ratio:
- PEG Ratio:
- Wall Street Target Price:
- Book Value:
- Dividend Share:
- Dividend Yield:
- Earnings Share:
- EPS Estimate Current Year:
- EPS Estimate Next Year:
- EPS Estimate Next Quarter:
- EPS Estimate Current Quarter:
- Most Recent Quarter:
- Profit Margin:
- Operating Margin TTM:
- Return On Assets TTM:
- Return On Equity TTM:
- Revenue TTM:
- Revenue Per Share TTM:
- Quarterly Revenue Growth YOY:
- Gross Profit TTM:
- Diluted Eps TTM:
- Quarterly Earnings Growth YOY:
Basic Information
- Type:
- Name:
- Exchange:
- Currency Code:
- Currency Name:
- Currency Symbol:
- Country Name:
- Fiscal Year End:
- IPO Date:
- International Domestic:
- Sector:
- Industry:
- Address:
- Country:
- Listings:
- Web URL:
- Full Time Employees:
- Updated At:
- Gic Sector:
- Gic Group:
- Gic Industry:
- Gic SubIndustry:
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. Address: 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670